Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9321791 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

Patent 9321791 was granted and assigned to Boehringer Ingelheim on April, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Boehringer Ingelheim

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

93217910

Patent Inventor Names

Elke Langkopf0

Frank Himmelsbach0

Matthias Eckhardt0

Michael Mark0

Mohammad Tadayyon0

Ralf Lotz0

Roland Maier0

Date of Patent

April 26, 2016

Patent Application Number

147487920

Date Filed

June 24, 2015

Patent Citations Received

‌

US Patent 11919903 Polymorphs

‌

US Patent 11911388 Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drug

‌

US Patent 11911387 Vasoprotective and cardioprotective antidiabetic therapy

Patent Primary Examiner

‌

Golam M. M. Shameem

Patent abstract

The present invention relates to substituted xanthines of general formula

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9321791 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API